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Regulation of endocytosis by protein phosphorylation and
dephosphorylation is critical to synaptic vesicle recycling.
Two groups have now identiﬁed the neuronal kinase Cdk5
(cyclin-dependent kinase 5) as an important regulator of this
process. Robinson and coworkers recently demonstrated
that Cdk5 is necessary for synaptic vesicle endocytosis
(SVE) (Tan et al., 2003), whereas a new report in this issue
claims that Cdk5 negatively regulates SVE (Tomizawa et
al., 2003). Careful examination of the data reveals a
model that helps resolve the apparently contradictory
nature of these reports.
 
Since Bernard Katz’s revolutionary studies in the 1950s
revealed the quantal nature of neurotransmission (del Castillo
and Katz, 1954), the synaptic vesicle life cycle has been
shown to include exocytosis, endocytosis, and trafficking.
After exocytosis and neurotransmitter release, the fused vesicles
are retrieved via endocytosis and trafficked back to eventually
become part of the readily releasable pool. Despite the equal
importance of each of these processes to neurotransmission,
knowledge of the molecular mechanisms and regulation of
endocytosis and the trafficking of vesicles has lagged far
behind that of exocytosis.
Synaptic vesicle endocytosis (SVE) is mediated by the
structurally unrelated dephosphin family of phosphopro-
teins, which includes amphiphysin I and dynamin I. These
proteins are constitutively phosphorylated and are dephos-
phorylated in response to excitation of the presynaptic terminal
 
by the Ca
 
2
 
 
 
-dependent phosphatase calcineurin (Cousin
and Robinson, 2001). Tan et al. (2003) have identified the
first dephosphin kinase as Cdk5. Despite its name, Cdk5 is
not cyclin dependent but requires either the neuronal cofactor
p35 or its homologue p39 for activity (Dhavan and Tsai,
2001). In studies reported in this issue, Tomizawa et al.
(2003) also identify Cdk5 as an endogenous dephosphin
kinase. However, the findings of the two groups differ sub-
stantially, and the implications of their data for the role of
Cdk5 in SVE appear to be in complete opposition.
One of the most obvious differences between the two
reports is the site of Cdk5 phosphorylation of dynamin I.
Tan et al. (2003) concluded that Ser774 and Ser778 are the
physiologically relevant phosphorylation sites, whereas To-
mizawa et al. (2003) ascribe this function to Thr780. Both
groups identified the phosphorylation site(s) of dynamin I
through mass spectrometric analysis and assigned physiologic
relevance to their respective sites with immunoblots of brain
tissue using phosphorylation state–specific antibodies. Perti-
nence to SVE was demonstrated with decreased levels of
phospho-dynamin I upon stimulation of synaptosomes or
hippocampal slices with KCl or electrical impulses. This effect
was reversed by addition of calcineurin inhibitors.
Tomizawa et al. (2003) provide particularly convincing
evidence that Cdk5 is responsible for phosphorylation of
 
dynamin I at Thr780 by probing tissue from p35
 
 
 
/
 
 
 
 mice
with their phosphorylation state–specific antibody. Tan et al.
(2003) employed a similar approach but relied on the use of
the Cdk5 inhibitor roscovitine (100 
 
 
 
M) rather than a
 
knockout system. Used at a 100 
 
 
 
M concentration, rosco-
vitine may have exerted a number of other known and
 
unknown effects. Tan et al. (2003) recognized these limitations
and compensated by confirming their results in cultured neu-
rons through the transfection of a dominant-negative form of
GFP–Cdk5. All in all, the use of phosphorylation state–specific
antibodies by both groups provides strong evidence that
dynamin I is indeed phosphorylated by Cdk5 at all three
identified sites and that these sites are physiologically relevant.
Other than the sites(s) of dynamin I phosphorylation by
Cdk5, the reports differ regarding the effect of phosphoryla-
tion of dynamin I on the binding of amphiphysin I. Tan et
al. (2003) reported no effect, whereas Tomizawa et al. (2003)
used two different binding assays to demonstrate a decrease
in binding to both whole-length amphiphysin I and its
isolated SH3 domain upon phosphorylation of dynamin I.
These seemingly contradictory results may not be so contra-
dictory, for one must remember that the two groups are
studying different phosphorylation sites on dynamin I. Alter-
natively, the discrepancy may result from the fact that Tan
et al. (2003) used only functional domains of both proteins,
whereas Tomizawa et al. (2003) used whole-length proteins
in their binding assays.
 
Another key difference between the two reports is the in
vivo phosphorylation of amphiphysin I by Cdk5. Tan et al.
 
(2003) asserted that Cdk5
 
 
 
s phosphorylation of amph-
iphysin I is strictly an in vitro occurrence, whereas Tomizawa
et al. (2003) identified five in vitro and in vivo Cdk5
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phosphorylation sites. Tan et al. (2003) performed a qua-
druple pull-down of dephosphins from 
 
32
 
P-labeled synap-
tosomes with protein domain affinity resins containing
portions of the SVE proteins 
 
 
 
-adaptin and endophilin I.
Since roscovitine did not block the increase in phospho-
amphiphysin I during the repolarization stage after KCl
stimulation, they concluded that amphiphysin I is not
phosphorylated by Cdk5 in vivo
 
.
 
 Alternative explanations
could exist if amphiphysin I has multiple Cdk5 phosphory-
lation sites, as Tomizawa et al. (2003) suggest. If amphi-
physin I has multiple phosphorylation sites and the de-
phosphorylation of any one of these sites enhances binding
to the 
 
 
 
-adaptin and endophilin I domains, the results may
be confounded. In other words, even if roscovitine de-
creases the level of phospho-amphiphysin I, this pull-down
assay may detect the same amount of phosphoprotein due
to the change in binding affinity.
In a different approach, Tomizawa et al. (2003) demon-
strate mobility shifts upon treatment with a calcineurin in-
hibitor in wild-type mice but not p35
 
 
 
/
 
 
 
 mice, presumably
due to the in vivo phosphorylation of amphiphysin I by
Cdk5. While this report and two others (Rosales et al.,
2000; Floyd et al., 2001) clearly demonstrate the in vitro
phosphorylation of amphiphysin I by Cdk5, more defini-
tive proof of the physiological significance of this reaction
in vivo must await future studies that employ phosphoryla-
tion state–specific antibodies.
Up until this point, the role of Cdk5 in SVE has only
been discussed on the molecular level in terms of what it
phosphorylates where. What really put these two papers at
odds are the fundamentally different observations concern-
ing the effects of Cdk5 inhibition on SVE. Tan et al. (2003)
performed a styryl dye study in which nerve terminals were
stimulated with KCl to undergo two rounds of endocytosis.
Despite the lack of effect on the first round of endocytosis,
treatment with 100 
 
 
 
M roscovitine significantly inhibited
the second round, and this corresponded with dramatic syn-
aptic vesicle depletion by electron microscopic analysis. Fur-
thermore, transfection of cultured neurons with a domi-
nant-negative form of Cdk5 resulted in a 50% decrease in
styryl dye uptake. Together, these studies suggest that Cdk5
is required for repetitive rounds of SVE.
In striking contrast, Tomizawa et al. (2003) performed
essentially the same styryl dye study in a primary culture
of hippocampal neurons and report seemingly opposite
results. Upon treatment with either 10 
 
 
 
M roscovitine or
another Cdk5 inhibitor, olomoucine, they found an in-
crease in styryl dye puncta size and number after electrical
stimulation. Treatment of primary hippocampal neurons
from p35
 
 
 
/
 
 
 
 mice with olomoucine did not produce any
changes, suggesting that the effect of olomoucine was
Cdk5 specific. In a cell-free assay, they observed massive
formation of small vesicles from liposomes when incu-
bated with dynamin I and amphiphysin I, but only in the
dephosphorylated forms. Furthermore, phosphorylation
inhibited the ability of dynamin I and amphiphysin I to
copolymerize into ring structures, a step believed to be
necessary in the final pinching off of synaptic vesicles.
The physiological significance of these in vitro systems is
difficult to ascertain when viewed in isolation. However,
taken in the context of the styryl dye study, these in vitro
systems make the hypothesis that Cdk5 suppresses SVE
very attractive.
So which is it? Is Cdk5 necessary for SVE or does Cdk5
suppress it? Only one of these hypotheses can be correct,
right? Perhaps not. The key could lie in recognition of the
fact that Tan et al. (2003) studied two rounds of endocyto-
sis, whereas Tomizawa et al. (2003) studied one. Consider
the following model (Fig. 1). The dephosphins exist in an
equilibrium between their phosphorylated and unphosphor-
ylated forms with Cdk5 and calcineurin mediating the in-
terconversion. Tomizawa et al. (2003) shift this equilibrium
in favor of the active, or unphosphorylated, form by using
Cdk5 inhibitors. The result is that endocytosis is enhanced
for the first round of endocytosis. But what about the next
round? Without Cdk5, the dephosphins cannot be rephos-
Figure 1. Schematic diagram depicting the dephosphin life cycle. 
Stimulation activates calcineurin-dependent dephosphorylation and 
results in SVE. During repolarization, Cdk5 rephosphorylates dephos-
phins for subsequent rounds of SVE. Inhibition of Cdk5 would 
enhance the first, but suppress the second, round of endocytosis. 
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phorylated in preparation for the subsequent round of en-
docytosis. In effect, they are stuck in an unphosphorylated
but inactive state, because they have already been “used”
once. Endocytosis fails after the first round, resulting in the
depletion of synaptic vesicles observed by Tan et al. (2003).
Further support for this model can be gained by closer in-
spection of the Tan et al. (2003) paper, particularly the por-
tions involving roscovitine treatment with one round of en-
docytosis. The bar graph depicting a 34% decrease in
retrieval efficiency for the second round of SVE actually also
depicts an 
 
 
 
12% increase for the first round. The set of
electron micrographs revealing a dramatic reduction in the
number of vesicles for the second round of SVE also reveals
an apparent increase in the number of large-sized vesicles for
the first round.
In conclusion, processes as complicated and as mysterious
as SVE cannot be adequately summarized with global state-
ments such as “Cdk5 is necessary for SVE” or “Cdk5 inhib-
its SVE.” Cdk5 may do both; it may inhibit the first round
of endocytosis but be necessary for the second round. Thus,
one kinase can be necessary for a process and yet at the same
time also suppress it.
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